Latin America

Latin American countries start greenlighting Covid treatments

Mexico leads the way after approving Pfizer’s paxlovid and Merck’s controversial new drug, molnupiravir

covid treatments
Photo: Shutterstock

In 2020 and 2021, Covid left a major mark on Latin America, though the situation is far from over, with the Omicron variant spreading quickly around the continent. Daily case records, set when Latin America was the global epicenter of the pandemic, are now being broken by countries throughout the region. Though, mercifully, deaths and hospitalizations lag behind.

There are, however, signs of hope on the horizon. Latin American countries are moving quickly to approve and purchase new treatments against coronavirus infections – a welcome change after the region trailed in the vaccine race.

The most notable example...

Access all of The Brazilian Report

Less expensive than a coffee!

Enjoy your 30-day limited-time offer for US$ 0.25 a week